These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6088022)

  • 1. Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer.
    Niell HB; Griffin JP; West WH; Neely CL
    Cancer; 1984 Oct; 54(7):1260-3. PubMed ID: 6088022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer.
    Niell HB; Griffin JP
    Med Pediatr Oncol; 1985; 13(6):341-5. PubMed ID: 3930930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
    Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.
    Nomura F; Shimokata K; Saito H; Sakai S; Watanabe A; Saka H
    Cancer Chemother Pharmacol; 1987; 20(4):324-6. PubMed ID: 2826032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinblastine-associated pulmonary toxicity in patients receiving combination therapy with mitomycin and cisplatin.
    Hoelzer KL; Harrison BR; Luedke SW; Luedke DW
    Drug Intell Clin Pharm; 1986 Apr; 20(4):287-9. PubMed ID: 3698826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study.
    Davis S; Tonato M; Crinò L; Colozza MA; Lubansky K; Grignani F
    Cancer; 1986 Sep; 58(5):1018-9. PubMed ID: 3015372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitomycin C, adriamycin and vinblastine after induction with cisplatin and VP-16 in the treatment of non-small cell lung carcinoma].
    De Marinis A; Mugnaini L; Antilli A; Mollica C; Mecarocci D; Conte S; Salvati F
    G Ital Chemioter; 1985; 32(1):73-5. PubMed ID: 3007255
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
    Bakowski MT; Crouch JC
    Cancer Treat Rev; 1983 Sep; 10(3):159-72. PubMed ID: 6311415
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study.
    Weick JK; Rainey JM; Livingston RB; Baker LH; O'Bryan RM; Chen TT
    Cancer Treat Rep; 1985 Jun; 69(6):583-5. PubMed ID: 2990709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F; Perry DJ; Goutsou M; Modeas C; Muchmore E; Rege V; Chahinian AP; Hirsh V; Poiesz B; Green MR
    Cancer; 1991 Jun; 67(12):2974-9. PubMed ID: 1646066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary experience with mitomycin, vinblastine and cisplatin (MVP) combination chemotherapy in the treatment of advanced non-small cell lung cancer at University Hospital, Kuala Lumpur.
    Lee SM
    Singapore Med J; 1990 Jun; 31(3):228-32. PubMed ID: 2168091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
    Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.
    Giaccone G; Bagatella M; Donadio M; Bonardi GM; Testore F; Ferrati P; Ciuffreda L; Calciati A
    Br J Cancer; 1987 Oct; 56(4):475-8. PubMed ID: 2825750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].
    Nakano H; Kurihara M; Saito R; Takise A; Tsuchiya S; Minato K; Takehara K; Saruya T; Kuwabara H; Fueki R
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2123-7. PubMed ID: 3013099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
    Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
    Chest; 1985 Mar; 87(3):368-72. PubMed ID: 2982552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma.
    Veeder MH; Jett JR; Su JQ; Mailliard JA; Foley JF; Dalton RJ; Etzell PS; Marschke RF; Kardinal CG; Maksymiuk AW
    Cancer; 1992 Nov; 70(9):2281-7. PubMed ID: 1394057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer.
    Mylonakis N; Tsavaris N; Bacoyiannis C; Karvounis N; Kakolyris S; Karabelis A; Beer M; Kosmidis P
    Ann Oncol; 1992 Feb; 3(2):127-30. PubMed ID: 1318742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].
    Nishimura M; Sugiura T; Urata A; Ota K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):54-60. PubMed ID: 2578274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of combination chemotherapy with continuously infused peplomycin (PEP), cis-dichlorodiammineplatinum (II) (CDDP) and mitomycin C (MMC) (PPM therapy)].
    Goto T; Furuta I; Urata A; Fukushima M; Okuma K; Oyama A; Murakami M; Ariyoshi Y; Nishimura M; Kurita S
    Nihon Gan Chiryo Gakkai Shi; 1983 Dec; 18(8):2054-60. PubMed ID: 6201578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.